In one study that looked at three-day food records for GLP-1 users, 72% took in less than recommended amounts of calcium, nearly two-thirds didn't get enough iron, and only 1.4% met vitamin D recommendations
[2] [3] In October 2023, the MHRA also approved tirzepatide (Mounjaro) for weight management in adults with an initial BMI of at least 30 kg/m (obesity), or from 27 kg/m to less than 30 kg/m (overweight) in the presence of at least one weight-related comorbidity
reduces postprandial glucagon (but NOT insulin secretionno insulinotropic effect)
typically, larger dosages lead to higher expenses
Its ingredients are commonly taken for zinc deficiency, immune support, cold symptoms.Based on those ingredients, 1,298 medications have a known interaction with it, the most serious rated major